We're off to the races!

FDA Identifies Biomarker for Immune Response to FVIII Products Used to Treat Hemophilia A

The following is a press release from the FDA. Read the press release on the FDA website here. Scientists at the U.S. Food and Drug Administration developed a technique that enables them to determine whether immune system cells called dendritic cells appear primed to trigger the production of antibodies against Factor VIII (FVIII) products used to […]

en_USEnglish